- Nachrichtendetail
-
05.06.2024 08:19:50 - dpa-AFX: *GILEAD SCIENCES' SELADELPAR SHOWS LONG-TERM EFFICACY, SAFETY IN PRIMARY BILIARY CHOLANGITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Gilead Sciences | 885823 | NASDAQ | 72,560 | 19.07.24 22:00:07 | -0,950 | -1,29% | 72,000 | 72,680 | 72,600 | 73,510 |
